Wen G Jiang Selected Research

Necrosis

1/2013	The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
1/2011	Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro.
7/2009	Vascular endothelial growth inhibitor in human cancer (Review).
1/2006	Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen G Jiang Research Topics

Disease

205	Neoplasms (Cancer) 01/2024 - 01/2002
139	Breast Neoplasms (Breast Cancer) 11/2023 - 08/2003
86	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2002
44	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2002
26	Lung Neoplasms (Lung Cancer) 01/2024 - 12/2005
20	Stomach Neoplasms (Stomach Cancer) 01/2024 - 11/2012
16	Colorectal Neoplasms (Colorectal Cancer) 05/2023 - 07/2009
16	Wounds and Injuries (Trauma) 11/2021 - 03/2007
14	Carcinogenesis 01/2023 - 06/2007
13	Disease Progression 05/2023 - 05/2015
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2005
9	Carcinoma (Carcinomatosis) 01/2021 - 01/2004
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 03/2016
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2010
5	Starvation 10/2017 - 08/2008
4	Ductal Carcinoma 10/2017 - 10/2003
4	Ovarian Neoplasms (Ovarian Cancer) 02/2017 - 06/2016
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 01/2013
4	Melanoma (Melanoma, Malignant) 10/2013 - 04/2011
4	Necrosis 01/2013 - 01/2006
3	Colonic Neoplasms (Colon Cancer) 05/2023 - 05/2005
3	Triple Negative Breast Neoplasms 01/2023 - 01/2018
3	Inflammation (Inflammations) 10/2021 - 12/2015
3	Lymphatic Metastasis 03/2017 - 09/2005
3	Hypoxia (Hypoxemia) 01/2017 - 10/2007
3	Wilms Tumor (Wilm's Tumor) 11/2016 - 12/2004
3	Pituitary Neoplasms (Pituitary Adenoma) 05/2015 - 08/2013
3	Kidney Neoplasms (Kidney Cancer) 01/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

131	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2003
51	Messenger RNA (mRNA)IBA 03/2020 - 09/2003
24	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2022 - 09/2003
22	Catalytic RNA (Ribozymes)IBA 05/2017 - 09/2003
21	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2023 - 02/2007
19	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2011
18	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2004
18	CytokinesIBA 02/2021 - 09/2002
11	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 05/2023 - 01/2004
11	hammerhead ribozymeIBA 01/2017 - 09/2004
9	TransglutaminasesIBA 01/2023 - 11/2003
9	Cadherins (E-Cadherin)IBA 01/2022 - 06/2005
8	yangzheng xiaojiIBA 01/2024 - 07/2012
8	LigandsIBA 01/2017 - 12/2003
8	Growth InhibitorsIBA 01/2017 - 01/2006
7	OsteopontinIBA 01/2023 - 01/2016
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2003
7	Small Interfering RNA (siRNA)IBA 04/2021 - 12/2010
7	Protein Isoforms (Isoforms)IBA 01/2021 - 04/2006
7	Peptide Hydrolases (Proteases)FDA Link 03/2013 - 04/2006
6	CateninsIBA 01/2022 - 09/2006
6	S100 Calcium Binding Protein A7IBA 01/2020 - 07/2004
6	N 30IBA 03/2019 - 12/2004
6	PaxillinIBA 01/2019 - 09/2008
6	InterleukinsIBA 03/2017 - 06/2006
5	Matrix Metalloproteinases (MMPs)IBA 12/2023 - 04/2006
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 12/2017
5	Bone Morphogenetic Protein ReceptorsIBA 01/2023 - 02/2007
5	EnzymesIBA 01/2023 - 04/2006
5	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2006
5	sodium-hydrogen exchanger regulatory factorIBA 03/2020 - 10/2013
5	Conditioned Culture MediaIBA 11/2018 - 06/2006
5	pigment epithelium-derived factorIBA 04/2018 - 12/2005
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 12/2003
5	Serine Proteases (Serine Protease)IBA 03/2013 - 06/2007
5	matriptase 2IBA 03/2013 - 06/2007
5	Bone Morphogenetic Protein 7IBA 06/2012 - 09/2007
4	Phosphotransferases (Kinase)IBA 12/2023 - 01/2021
4	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 01/2017
4	Protein Kinases (Protein Kinase)IBA 01/2021 - 03/2016
4	Cell Adhesion MoleculesIBA 01/2021 - 01/2002
4	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2020 - 05/2008
4	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019 - 04/2010
4	AntigensIBA 03/2016 - 01/2011
4	OccludinIBA 03/2016 - 08/2003
4	Growth Differentiation Factor 9IBA 03/2012 - 11/2010
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2010 - 12/2005
4	matrigelIBA 04/2010 - 03/2005
4	Placenta Growth FactorIBA 09/2008 - 12/2003
3	ClaudinsIBA 11/2023 - 01/2011
3	Complement Inactivating AgentsIBA 05/2023 - 10/2015
3	ezrinIBA 05/2023 - 05/2003
3	Phenobarbital (Luminal)FDA Link 01/2023 - 12/2017
3	Cyclin D1IBA 01/2022 - 07/2011
3	Fluorouracil (Carac)FDA LinkGeneric 04/2021 - 01/2014
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2019 - 05/2014
3	Epidermal Growth Factor (EGF)IBA 03/2017 - 08/2015
3	plexinIBA 01/2017 - 01/2014
3	Sodium-Hydrogen ExchangersIBA 01/2017 - 10/2013
3	RANK LigandIBA 01/2017 - 01/2013
3	Cysteine (L-Cysteine)FDA Link 11/2016 - 12/2004
3	Connective Tissue Growth FactorIBA 11/2016 - 12/2004
3	A-factor (Streptomyces)IBA 02/2016 - 06/2007
3	Proto-Oncogene Proteins c-metIBA 08/2015 - 01/2004
3	claudin 16IBA 01/2015 - 09/2008
3	Protein Tyrosine PhosphatasesIBA 11/2013 - 01/2012
3	Wiskott-Aldrich Syndrome Protein FamilyIBA 11/2010 - 10/2008

Therapy/Procedure

43	Therapeutics 01/2023 - 07/2002
15	Drug Therapy (Chemotherapy) 11/2023 - 07/2012
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2016 - 03/2015
4	Neoadjuvant Therapy 01/2024 - 01/2020
3	Aftercare (After-Treatment) 11/2018 - 05/2007